Skip to main content
Premium Trial:

Request an Annual Quote

All About the Narrative

MIT's Technology Review speaks with Knome's Jorge Conde about his company's $100,000 service, down from $350,000 when it launched in 2007. Conde doesn't say how many people Knome has sequenced but does note that 80 percent have been men in their mid-50s and that many customers are from outside the US. Sequencing is done at the Beijing Genomics Institute, then analyzed at Knome, and given to the customer on a USB drive during a day-long meeting. Knome has also recently partnered with Illumina to develop a more automated interpretation service to go along with Illumina's $48,000 sequencing service. "In the long-term, [analysis] will be a big driver of value," Conde says. "We will see the high price point go away, and the real value for both individuals and companies will be to provide an ongoing narrative."

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.